drugset
drugset / Trial / NCT05546359

Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients

NCT05546359 ↗

Phase 2/3 Completed 453 enrolled Acacia Pharma Ltd Amicus CD LLC · collabPremier Research · collab
RandomizedParallel-groupTriple-blindPrevention

Summary

Randomized, double-blind, pediatric trial of amisulpride for prophylaxis of post operative nausea and vomiting

Timeline

Start
2024-01-18
Primary completion
2025-06-03
Completion
2025-06-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Amisulpride Small molecule 0.035 mg/kg Intravenous
Subject Amisulpride Small molecule 0.07 mg/kg Intravenous
Background Dexamethasone Small molecule — Intravenous

Indications

No indication recorded.